LONDON--(BUSINESS WIRE)--The Cell Therapy Catapult has published its annual survey of the GMP licensed cell and gene manufacturing capability and capacity in the UK, which shows growth in the cell therapy industry to April 2015. Key findings include:
•25% increase in the numbers of highly-skilled staff at cell therapy facilities
•Addition of 2 cell therapy manufacturing centres
•16% growth in the number of clean-rooms.
In addition, the report highlights that capacity not already committed to manufacturing, has decreased from 45% to 26%, demonstrating that the expanded capacity is rapidly filling up. This is reflected in the Cell Therapy Catapult’s recently reported 24% rise in the number of clinical trials being carried out in the UK.
Help employers find you! Check out all the jobs and post your resume.
